These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16370163)

  • 21. [Diffuse pulmonary hemorrhage associated with antineutrophil cytoplasmic antibodies. Findings of high-resolution computerized tomography. A case report].
    Galeotti R; Sala S; Rosina G; Mannella P
    Radiol Med; 1997 Dec; 94(6):685-7. PubMed ID: 9524614
    [No Abstract]   [Full Text] [Related]  

  • 22. Vasculitis: clinical approach, pathophysiology and treatment.
    Kallenberg CG
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):656-9. PubMed ID: 11020951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antineutrophil cytoplasmic antibody-associated vasculitides.
    Seo P; Stone JH
    Am J Med; 2004 Jul; 117(1):39-50. PubMed ID: 15210387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infectious complications of immunosuppressive treatment for anti-neutrophil cytoplasm antibody-related vasculitis.
    Koselj-Kajtna M; Koselj M; Rott T; Kandus A; Bren A
    Transplant Proc; 2002 Nov; 34(7):3001-2. PubMed ID: 12431683
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis (CYCLOPS study)].
    Kötter I
    Z Rheumatol; 2009 Sep; 68(7):575-7. PubMed ID: 19652987
    [No Abstract]   [Full Text] [Related]  

  • 26. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
    Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is new in systemic vasculitis?
    Kallenberg CG; Tervaert JW
    Ann Rheum Dis; 2000 Nov; 59(11):924-5. PubMed ID: 11053075
    [No Abstract]   [Full Text] [Related]  

  • 28. Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis.
    Hebert LA; Rovin BH
    Ann Intern Med; 2010 Jan; 152(1):64; author reply 65. PubMed ID: 20048278
    [No Abstract]   [Full Text] [Related]  

  • 29. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
    Lapraik C; Watts R; Bacon P; Carruthers D; Chakravarty K; D'Cruz D; Guillevin L; Harper L; Jayne D; Luqmani R; Mooney J; Scott D;
    Rheumatology (Oxford); 2007 Oct; 46(10):1615-6. PubMed ID: 17804455
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis.
    Stegeman CA
    Nephrol Dial Transplant; 2002 Dec; 17(12):2077-80. PubMed ID: 12454214
    [No Abstract]   [Full Text] [Related]  

  • 31. Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Sanders JS; Slot MC; Stegeman CA
    N Engl J Med; 2003 Nov; 349(21):2072-3; author reply 2072-3. PubMed ID: 14627795
    [No Abstract]   [Full Text] [Related]  

  • 32. Pancytopenia in ANCA associated vasculitis: response to immunosuppressive therapy.
    Letellier E; Cunningham J; Feakins RM; Hughes GR; D'Cruz DP
    Clin Exp Rheumatol; 2003; 21(3):415-6. PubMed ID: 12846080
    [No Abstract]   [Full Text] [Related]  

  • 33. ANCA-associated small-vessel vasculitis.
    Mansi IA; Opran A; Rosner F
    Am Fam Physician; 2002 Apr; 65(8):1615-20. PubMed ID: 11989638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhodococcus equi infection during treatment of a c-ANCA positive vasculitis: a case report.
    Garthwaite EA; Border DJ; Jones CH; Worth DP
    Rheumatol Int; 2007 Jan; 27(3):285-7. PubMed ID: 17013608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of ANCA-positive vasculitis with thyroid disease.
    Rothe HM; Siegmund J; Müller H; Wopperer J
    Nephrol Dial Transplant; 2008 Jun; 23(6):2107; author reply 2107-8. PubMed ID: 18323519
    [No Abstract]   [Full Text] [Related]  

  • 36. 4. Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis: from molecular analysis to bedside.
    Yoshida M
    Intern Med; 2002 Jan; 41(1):47-9. PubMed ID: 11838592
    [No Abstract]   [Full Text] [Related]  

  • 37. [What's new in systemic vasculitis?].
    Müller A; Csernok E
    Z Rheumatol; 2002 Oct; 61(5):610-2. PubMed ID: 12399893
    [No Abstract]   [Full Text] [Related]  

  • 38. Antineutrophil cytoplasmic antibodies (ANCA) and small vessel vasculitis.
    Mareen P; Van De Walle S; Bernaert P; Vanhouteghem H; Dierick J
    Acta Clin Belg; 2003; 58(3):193-200. PubMed ID: 12945480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [ANCA vasculitis].
    Bernis C
    Nefrologia; 2003; 23(2):103-6. PubMed ID: 12778872
    [No Abstract]   [Full Text] [Related]  

  • 40. Various forms of life in antineutrophil cytoplasmic antibody-associated vasculitis.
    Hogan SL; Falk RJ; Nachman PH; Jennette JC
    Ann Intern Med; 2006 Mar; 144(5):377-8; author reply 378-9. PubMed ID: 16520483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.